SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001214659-22-008985
Filing Date
2022-07-19
Accepted
2022-07-19 16:31:10
Documents
68
Period of Report
2022-04-30

Document Format Files

Seq Description Document Type Size
1 g7722110k.htm   iXBRL 10-K 1523275
2 EXHIBIT 23.1 ex23_1.htm EX-23.1 2473
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 8934
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 9000
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 6933
11 GRAPHIC p13chart.jpg GRAPHIC 221197
12 GRAPHIC p5chart.jpg GRAPHIC 111696
  Complete submission text file 0001214659-22-008985.txt   6497541

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE alxneuro-20220430.xsd EX-101.SCH 54084
7 XBRL CALCULATION FILE alxneuro-20220430_cal.xml EX-101.CAL 45578
8 XBRL DEFINITION FILE alxneuro-20220430_def.xml EX-101.DEF 192644
9 XBRL LABEL FILE alxneuro-20220430_lab.xml EX-101.LAB 376016
10 XBRL PRESENTATION FILE alxneuro-20220430_pre.xml EX-101.PRE 293406
62 EXTRACTED XBRL INSTANCE DOCUMENT g7722110k_htm.xml XML 653119
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-40483 | Film No.: 221091883
SIC: 2834 Pharmaceutical Preparations